RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Condition: Hepatocellular Carcinoma Intervention: Drug: Radiation therapy and systemic anti-PD-1 immunotherapy for patients with advanced hepatocellular carcinoma Sponsor: Guangxi Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | Radiation Therapy | Research